Found: 33
Select item for more details and to access through your institution.
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00962-z
- By:
- Publication type:
- Article
Myeloid-derived suppressor cells as therapeutic target in hematological malignancies.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00349
- By:
- Publication type:
- Article
Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis.
- Published in:
- Journal of Pathology, 2023, v. 260, n. 2, p. 112, doi. 10.1002/path.6066
- By:
- Publication type:
- Article
Targeting the β<sub>2</sub>‐adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism.
- Published in:
- Journal of Pathology, 2023, v. 259, n. 1, p. 69, doi. 10.1002/path.6020
- By:
- Publication type:
- Article
Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation.
- Published in:
- Journal of Pathology, 2017, v. 241, n. 4, p. 534, doi. 10.1002/path.4860
- By:
- Publication type:
- Article
Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression.
- Published in:
- Journal of Pathology, 2016, v. 239, n. 2, p. 162, doi. 10.1002/path.4712
- By:
- Publication type:
- Article
Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 2, p. 904, doi. 10.3390/ijms23020904
- By:
- Publication type:
- Article
Metabolic Features of Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 4, p. 1200, doi. 10.3390/ijms19041200
- By:
- Publication type:
- Article
Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo.
- Published in:
- Acta Pharmacologica Sinica, 2013, v. 34, n. 5, p. 699, doi. 10.1038/aps.2012.182
- By:
- Publication type:
- Article
The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1016059
- By:
- Publication type:
- Article
Radiotheranostic Agents in Hematological Malignancies.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.911080
- By:
- Publication type:
- Article
ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation.
- Published in:
- Stem Cell Research & Therapy, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13287-020-02037-3
- By:
- Publication type:
- Article
Upregulation of miR-135b Is Involved in the Impaired Osteogenic Differentiation of Mesenchymal Stem Cells Derived from Multiple Myeloma Patients.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0079752
- By:
- Publication type:
- Article
The Transfer of Sphingomyelinase Contributes to Drug Resistance in Multiple Myeloma.
- Published in:
- Cancers, 2019, v. 11, n. 12, p. 1823, doi. 10.3390/cancers11121823
- By:
- Publication type:
- Article
AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1727, doi. 10.3390/cancers11111727
- By:
- Publication type:
- Article
Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma.
- Published in:
- Cancers, 2014, v. 6, n. 3, p. 1363, doi. 10.3390/cancers6031363
- By:
- Publication type:
- Article
RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1286700
- By:
- Publication type:
- Article
The Use of Murine Models for Studying Mechanistic Insights of Genomic Instability in Multiple Myeloma.
- Published in:
- Frontiers in Genetics, 2019, p. 1, doi. 10.3389/fgene.2019.00740
- By:
- Publication type:
- Article
Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy.
- Published in:
- Cell Communication & Signaling, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12964-024-01699-3
- By:
- Publication type:
- Article
The antigen‐binding moiety in the driver's seat of CARs.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 1, p. 306, doi. 10.1002/med.21818
- By:
- Publication type:
- Article
Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma.
- Published in:
- Cancer Biology & Medicine, 2021, v. 18, n. 3, p. 721, doi. 10.20892/j.issn.2095-3941.2020.0430
- By:
- Publication type:
- Article
Mesenchymal Stromal Cell Sialylation Modulates Antitumor Immune Responses In Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e93, doi. 10.1016/j.clml.2019.09.152
- By:
- Publication type:
- Article
The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Targeted α-Therapy Using <sup>225</sup>Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 5, p. 751, doi. 10.2967/jnumed.122.264752
- By:
- Publication type:
- Article
Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0249-x
- By:
- Publication type:
- Article
AXL as immune regulator and therapeutic target in Acute Myeloid Leukemia: from current progress to novel strategies.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00566-8
- By:
- Publication type:
- Article
Fueling CARs: metabolic strategies to enhance CAR T-cell therapy.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00535-1
- By:
- Publication type:
- Article
Metabolic cross-talk within the bone marrow milieu: focus on multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40164-022-00303-z
- By:
- Publication type:
- Article
Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.979569
- By:
- Publication type:
- Article
Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1389018
- By:
- Publication type:
- Article
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia.
- Published in:
- Theranostics, 2024, v. 14, n. 7, p. 2656, doi. 10.7150/thno.91456
- By:
- Publication type:
- Article
Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02250-3
- By:
- Publication type:
- Article
Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 5634, doi. 10.3390/ijms25115634
- By:
- Publication type:
- Article